;
Hemodialysis Powder Solution Market: Segmented: By Type (A liquid B liquid, A liquid B powder, and A powder B powder), By Application (Hospital, Laboratory and Others), And Region - Global Analysis of Market Size, Share & Trends For 2020-2021 And Forecasts To 2031
[ 170 + Pages Research Report ] Hemodialysis Powder Solution market to surpass USD 7,503.9 million by 2031 from USD 4,828.1 million in 2021 at a CAGR of 5.8% in the coming years, i.e., 2021-31.
Hemodialysis powder solutions are dialysates or concentrates which are utilized to extract waste materials from the blood and retain important components from leaving the blood. It helps in regulating electrolyte and acid-base balance during chronic renal failure. Hemodialysis is a process of removing blood from the body, filtering waste through a dialyzer or artificial kidney, and returning the clean blood to the body. Hemodialysis Powder Solution is fragmented by type into A liquid B liquid, A liquid B powder, and A powder B powder. It has major applications in public hospitals, nursing homes, personal care, and private clinic.
Hemodialysis Powder Solution market is expected to project a notable CAGR of 5.8% in 2031.
Growing geriatric population, rising number of patients suffering from chronic kidney diseases, and improvement in renal care facilities will drive the growth of Global Hemodialysis Powder Solution market.
A powder B powder segment holds the largest market share
Global Hemodialysis Powder Solution market is classified on the basis of type A liquid B liquid, A liquid B powder, and A powder B powder. A powder B powder segment is dominating the market with the largest share. A powder B powder (Part A+B) are considered as the most suitable concentrate for carrying out hemodialysis which is driving the growth of the segment.
Hospital segment holds the largest market share
Global Hemodialysis Powder Solution market is classified on the basis of application in hospitals, Laboratories, and Others. Hospital segment is dominating the market with the largest share. The growth is attributed to the huge demand for hemodialysis powder solutions in hospitals. Moreover, hospitals have highly professional and experienced healthcare personnel and hence are preferred by patients for treatment.
Increasing Prevalence of Chronic Kidney Diseases
Increasing prevalence of cardiovascular disorders and chronic kidney diseases are leading to renal failure which is driving the growth of Global Hemodialysis Powder Solution market. Many patients are diagnosed with kidney diseases every year and they require proper dialysis or have to undergo a kidney transplants. The people affected by coronavirus are developing chronic kidney diseases and other medical conditions. Furthermore, rising geriatric population in the world is also propelling the growth of Global Hemodialysis Powder Solution market.
Improvement in Renal Care Facilities
The demand for efficient renal care facilities has increased owing to growing number of patients suffering from chronic kidney diseases. Growing availability of nephrologists have contributed to the growth of renal care facilities. Moreover, rising demand for home care dialysis services over the past few years and growing investments in the development of renal treatment centers in emerging nations will fuel the growth of Global Hemodialysis Powder Solution market.
High Manufacturing Costs
The manufacturing costs of Hemodialysis Powder Solution is very high which is hampering the market growth. Moreover, approval procedure is very time taking which is also restraining the growth of the market.
Global Hemodialysis Powder Solution market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America is expected to hold a largest share in the hemodialysis powder solution market in the near future owing to growing demand for dialysates in the region, presence of major market players, rapid advancements in technology, escalating prevalence of renal disorders, and booming healthcare sector.
Covid-19 had severely affected economic activities across the world. Many countries had to impose lockdowns and strict social distancing norms in order to control the spread of Coronavirus. Health care industry had to face new challenges and hospitals had to hold many health services. There was acute shortage of healthcare workers and many were infected by the coronavirus. Global Hemodialysis Powder Solution market was negatively impacted by covid-19 as patients lost access to hemodialysis procedures due to nationwide lockdown and many clinics and hospitals had to stop their operations temporarily. However, Global Hemodialysis Powder Solution market is expected to grow at a significant rate during the forecast period
Hemodialysis Powder Solution Market is further segmented by region into:
Hemodialysis Powder Solution Market Segments:
Report Attribute | Details |
Market size value in 2021 | USD 4,828.1 million |
Revenue forecast in 2031 | USD 7,503.9 million |
Growth Rate | CAGR of 5.8% from 2021 to 2031 |
Base year for estimation | 2021 |
Quantitative units | Revenue in USD million and CAGR from 2021 to 2031 |
Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered | Type, Application, and Region |
Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
Key companies profiled | Baxter International Inc., Fresenius SE & Co. KGaA, Rockwell Medical, Inc., Farmasol, WEGO Health Co., Ltd., O.M.A.R S.r.l Pharmaceutical Blister Solution, Renacon Pharma Limited, Melson Medical Corporation Limited, B. Braun, Weigao group, Tom Medical, Gambro, Chief Medical Supplies, and Other Prominent Players |
Global Hemodialysis Powder Solution market size was estimated at USD 4,828.1 million in 2021 and is expected to reach USD 7,503.9 million in 2031.
Hemodialysis powder solutions are dialysates or concentrates which are utilized to extract waste materials from the blood and retain important components from leaving the blood. It helps in regulating electrolyte and acid base balance during chronic renal failure. Hemodialysis is a process of removing blood from the body, filtering waste through a dialyzer or artificial kidney and returning the clean blood to the body.
A powder B powder, and Hospital segment accounted for the largest Global Hemodialysis Powder Solution market share.
Key players: Baxter International Inc., Fresenius SE & Co. KGaA, Rockwell Medical, Inc., Farmasol, WEGO Health Co., Ltd., O M.A.R S.r.l Pharmaceutical Blister Solution, Renacon Pharma Limited, Melson Medical Corporation Limited, B. Braun, Weigao group, Tom Medical, Gambro, Chief Medical Supplies, and Other Prominent Players are the key players in the Global Hemodialysis Powder Solution market.
Increasing Prevalence of Chronic Kidney Diseases and Improvement in Renal Care Facilities are the factors driving the Global Hemodialysis Powder Solution market.
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT